AAAAAA
Results: 26-38/38
Authors:
Zhai, J
Schmidt, AG
Hoit, BD
Kimura, Y
MacLennan, DH
Kranias, EG
Citation: J. Zhai et al., Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo, J BIOL CHEM, 275(14), 2000, pp. 10538-10544
Authors:
Frank, K
Tilgmann, C
Shannon, TR
Bers, DM
Kranias, EG
Citation: K. Frank et al., Regulatory role of phospholamban in the efficiency of cardiac sarcoplasmicreticulum Ca2+ transport, BIOCHEM, 39(46), 2000, pp. 14176-14182
Authors:
Schmidt, AG
Kranias, EG
Citation: Ag. Schmidt et Eg. Kranias, Genetic approaches to elucidate the regulatory role of phospholamban in the heart, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 39-52
Authors:
Lalli, MJ
Shimizu, S
Sutliff, RL
Kranias, EG
Paul, RJ
Citation: Mj. Lalli et al., [Ca2+](i) homeostasis and cyclic nucleotide relaxation in aorta of phospholamban-deficient mice, AM J P-HEAR, 46(3), 1999, pp. H963-H970
Authors:
Kadambi, VJ
Ball, N
Kranias, EG
Walsh, RA
Hoit, BD
Citation: Vj. Kadambi et al., Modulation of force-frequency relation by phospholamban in genetically engineered mice, AM J P-HEAR, 45(6), 1999, pp. H2245-H2250
Authors:
Minamisawa, S
Hoshijima, M
Chu, GX
Ward, CA
Frank, K
Gu, YS
Martone, ME
Wang, YB
Ross, J
Kranias, EG
Giles, WR
Chien, KR
Citation: S. Minamisawa et al., Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction isthe critical calcium cycling defect in dilated cardiomyopathy, CELL, 99(3), 1999, pp. 313-322
Authors:
Brittsan, AG
Kiss, E
Edes, I
Grupp, IL
Grupp, G
Kranias, EG
Citation: Ag. Brittsan et al., The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions, J MOL CEL C, 31(9), 1999, pp. 1725-1737
Authors:
Yatani, A
Frank, K
Sako, H
Kranias, EG
Dorn, GW
Citation: A. Yatani et al., Cardiac-specific overexpression of G alpha q alters excitation-contractioncoupling in isolated cardiac myocytes, J MOL CEL C, 31(7), 1999, pp. 1327-1336
Authors:
Hoit, BD
Tramuta, DA
Kadambi, VJ
Dash, R
Ball, N
Kranias, EG
Walsh, RA
Citation: Bd. Hoit et al., Influence of transgenic overexpression of phospholamban on postextrasystolic potentiation, J MOL CEL C, 31(11), 1999, pp. 2007-2015
Authors:
Pan, BS
Hannon, JD
Wiedmann, R
Potter, JD
Kranias, EG
Shen, YT
Johnson, RG
Housmans, PR
Citation: Bs. Pan et al., Effects of isoproterenol on twitch contraction of wild type and phospholamban-deficient murine ventricular myocardium, J MOL CEL C, 31(1), 1999, pp. 159-166
Authors:
Sutliff, RL
Hoying, JB
Kadambi, VJ
Kranias, EG
Paul, RJ
Citation: Rl. Sutliff et al., Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation - Evidence from phospholamban gene-ablated mice, CIRCUL RES, 84(3), 1999, pp. 360-364
Authors:
Tepe, NM
Lorenz, JN
Yatani, A
Dash, R
Kranias, EG
Dorn, GW
Liggett, SB
Citation: Nm. Tepe et al., Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling, BIOCHEM, 38(50), 1999, pp. 16706-16713
Authors:
Chu, GX
Li, L
Sato, Y
Harrer, JM
Kadambi, VJ
Hoit, BD
Bers, DM
Kranias, EG
Citation: Gx. Chu et al., Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo, J BIOL CHEM, 273(50), 1998, pp. 33674-33680